For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Research and development expenses | 37 | 309* | 73 | 141 |
| General and administrative expenses | 186 | 86* | 178 | 174 |
| Operating loss | -223 | -395* | -251 | -315 |
| Total financial expense | -6 | -17* | -4 | -7 |
| Net loss | -229 | -413 | -255 | -322 |
| Basic EPS | 0.01 | -0.021 | 0.01 | 0.02 |
| Diluted EPS | 0.01 | -0.021 | 0.01 | 0.02 |
| Basic Average Shares | 20,176,418 | 19,402,321 | 19,626,418 | 19,626,418 |
| Diluted Average Shares | 20,176,418 | 19,402,321 | 19,626,418 | 19,626,418 |